Agios Pharmaceuticals, Inc. Share Price
NASDAQ: AGIOHealthcare
Live Agios Pharmaceuticals, Inc. Share Price Chart
O H L
Agios Pharmaceuticals, Inc. Performance Overview
Days Range
▼
$33.21Low
$33.21High
Markets Today
| Previous Close | $33.61 |
|---|---|
| Open | $33.21 |
| Volume | 77,065 |
| Day's Range | $33.21 - $33.21 |
| 52W Range | $22.24 - $46.00 |
| Market Cap | $1.97 B |
Historical Performance
| 1M Returns | -2.30 |
|---|---|
| 3M Returns | -1.61 |
| 6M Returns | +19.48 |
| 1Y Returns | -11.44 |
| 5Y Returns | -28.70 |
| 10Y Returns | -29.35 |
Agios Pharmaceuticals, Inc. Fundamentals
| Market Cap | $1.97 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $54.03 M |
| ROE TTM | -0.30 |
| EPS TTM | $-7.01 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.91 |
| EBITDA | $-466.95 M |
| Profit Margin | -764.01 |
| Market Cap | $1.97 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $54.03 M |
| ROE TTM | -0.30 |
| EPS TTM | $-7.01 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.91 |
| EBITDA | $-466.95 M |
| Profit Margin | -764.01 |
Agios Pharmaceuticals, Inc. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $8.73 M | $12.46 M | $12.88 M | $19.97 M | $20.75 M | $44.74 M |
| Gross Profit + | $7.64 M | $10.75 M | $11.20 M | $18.09 M | $19.43 M | $41.75 M |
| Operating Income | -$106.63 M | -$127.06 M | -$116.87 M | -$121.58 M | -$110.03 M | -$110.55 M |
| EBITDA | -$105.35 M | -$125.80 M | -$115.50 M | -$120.31 M | -$108.66 M | -$109.20 M |
| Interest Expense | $16.09 M | $14.51 M | $0 | $0 | $10.79 M | $9.73 M |
| Depreciation | $1.28 M | $1.26 M | $1.37 M | $1.27 M | $1.36 M | $1.35 M |
| Income Before Tax | -$89.29 M | -$112.02 M | -$103.43 M | -$109.06 M | -$99.11 M | -$100.70 M |
| Income Tax Expense | $0 | $0 | $0 | -$1.02 M | $0 | $0 |
| Net Income + | -$89.29 M | -$112.02 M | -$103.43 M | -$108.04 M | -$99.11 M | -$100.70 M |
| Net Profit Margin | -1023.25% | -899.4% | -803.05% | -541.09% | -477.74% | -225.06% |
Agios Pharmaceuticals, Inc. Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $74.00 K | $74.00 K | $74.00 K | $75.00 K | $76.00 K | $76.00 K |
| Reserve & Surplus | -$237.85 M | -$350.23 M | -$453.67 M | -$561.71 M | -$660.82 M | -$761.52 M |
| Non-Current Liabilities | $36.62 M | $31.27 M | $26.62 M | $21.91 M | $17.03 M | $12.19 M |
| Current Liabilities | $52.37 M | $70.41 M | $74.76 M | $82.21 M | $58.84 M | $70.22 M |
| Total Liabilities | $88.99 M | $101.68 M | $101.38 M | $104.11 M | $75.88 M | $82.40 M |
| Fixed Assets | $11.07 M | $10.58 M | $10.68 M | $10.78 M | $10.57 M | $9.95 M |
| Current Assets | $968.62 M | $1.02 B | $1.03 B | $942.05 M | $834.84 M | $717.67 M |
| Total Assets | $1.56 B | $1.47 B | $1.39 B | $1.30 B | $1.18 B | $1.11 B |
Agios Pharmaceuticals, Inc. Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$89.29 M | -$112.02 M | -$103.43 M | -$108.04 M | -$99.11 M | -$100.70 M |
| Operating Cash Flow | -$111.49 M | -$77.12 M | -$88.15 M | -$96.21 M | -$118.92 M | -$57.31 M |
| Investing Cash Flow | $112.59 M | $78.97 M | $95.56 M | $90.08 M | $141.31 M | $40.21 M |
| Financing Cash Flow | $1.62 M | $65.00 K | $4.43 M | $2.56 M | $2.08 M | $3.15 M |
| Change in Cash | $2.72 M | $1.91 M | $11.84 M | -$3.58 M | $24.47 M | -$13.95 M |
Agios Pharmaceuticals, Inc. Return Calculator
The Agios Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$7,015
Invested Amount$10,000
Est. Returns$-2,985
About Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.
Popular Stocks
FAQs
What is the share price of Agios Pharmaceuticals, Inc. today?
Agios Pharmaceuticals, Inc. (AGIO) share price as of September 18, 2026 is $33.07. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Agios Pharmaceuticals, Inc.?
Yes, Indian Investors can invest in the Agios Pharmaceuticals, Inc. (AGIO) Share by opening an international trading account with Angel One.
How can I purchase Agios Pharmaceuticals, Inc. shares in India?
Purchasing Agios Pharmaceuticals, Inc. (AGIO) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Agios Pharmaceuticals, Inc. (AGIO) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Agios Pharmaceuticals, Inc.?
Yes, you can purchase fractional shares of Agios Pharmaceuticals, Inc. (AGIO) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Agios Pharmaceuticals, Inc.?
The market capitalization of Agios Pharmaceuticals, Inc. on September 18, 2026, is $1.97 B.
In which sector Agios Pharmaceuticals, Inc. belongs?
Agios Pharmaceuticals, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Agios Pharmaceuticals, Inc. stocks?
In order to invest in Agios Pharmaceuticals, Inc. (AGIO) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
